results from a phase i trial of tinostamustine in patients with r/r classical hl
Published 7 months ago • 58 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
4:48
an insight into the management of cytopenias in mf
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:30
insights into the manifest-2 study
-
0:50
insights into the phase ii window-2 trial
-
3:35
epigenomics in precision oncology
-
2:09
encapsulation with alginate
-
22:36
dive into digital pathology market
-
1:03
insights into the cartitude-6 trial: rationale and design
-
2:00
the role of fedratinib in 2024 and beyond
-
1:44
insights into the phase ii tidal study
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:34
are thrombotic risk and progression in et predictable?
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:56
insights into the healthtree foundation
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
2:41
an overview of the latest advances in hematology
-
1:53
parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma